샘플 요청 목록

 카트 문의
시장보고서
상품코드
1572032

세계의 글루코스 바이오센서 시장

Glucose Biosensors
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 93 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

글루코스 바이오센서 세계 시장은 2030년까지 41억 달러에 달할 것으로 전망

2023년에 36억 달러로 추정되는 글루코스 바이오센서 세계 시장은 2023-2030년 분석 기간 동안 연평균 2.1% 성장하여 2030년에는 41억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 병원 최종 용도 부문은 CAGR 1.8%를 기록하여 분석 기간 종료 시점에 15억 달러에 도달할 것으로 예상됩니다. 홈케어 진단 최종 용도 분야의 성장률은 분석 기간 동안 CAGR 2.5%로 추정됩니다.

미국 시장 9억 6,030만 달러, 중국은 CAGR 3.1%로 성장 전망

미국의 글루코스 바이오센서 시장은 2023년 9억 6,030만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 7억 6,560만 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 3.1%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 1.5%와 1.9%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.8%의 성장률을 보일 것으로 예상됩니다.

세계 글루코스 바이오센서 시장 - 주요 동향 및 촉진요인 요약

글루코스 바이오센서는 어떻게 당뇨병 관리를 강화하는가?

글루코스 바이오센서는 당뇨병 관리의 중요한 도구로, 환자에게 혈당 수치를 실시간으로 모니터링할 수 있는 기능을 제공합니다. 혈당 측정기 및 연속 혈당 모니터링(CGM) 기기에 필수적인 이 센서들은 효소 반응이나 전기 화학적 감지 방법을 사용하여 혈당 농도를 측정하며, 24시간 추적 가능한 연속 혈당 모니터링 시스템은 환자에게 인슐린 투여, 식사 및 활동과 관련된 정보에 입각한 의사결정을 내릴 수 있도록 더 많은 데이터를 제공합니다. 인슐린 투여, 식단, 활동에 대한 정보에 입각한 의사결정을 내릴 수 있는 더 많은 데이터를 제공함으로써 당뇨병 관리를 획기적으로 개선했습니다. 전 세계적으로 당뇨병 유병률이 증가함에 따라 정확하고 신뢰할 수 있으며 사용자 친화적인 글루코스 바이오센서에 대한 수요가 증가하고 있으며, 환자가 자신의 질병을 더 잘 관리할 수 있도록 돕고 있습니다.

글루코스 바이오센서의 주요 부문과 응용 분야는?

글루코스 바이오센서 시장은 전기화학 바이오센서, 광학 바이오센서, 효소 바이오센서 등 기술별로 세분화되어 있습니다. 전기화학 바이오센서는 효소 반응에 의해 생성된 전기 신호를 통해 포도당 농도를 측정하는 것으로, 정확성, 저렴한 가격, CGM 장치 및 포도당 측정기에서의 대중화로 인해 시장을 장악하고 있습니다. 빛에 기반한 감지 방법을 사용하는 광학식 바이오센서도 특히 비침습적 모니터링 시스템에서 인기를 끌고 있습니다. 응용 측면에서 글루코스 바이오센서는 주로 자가 혈당 측정(SMBG) 시스템 및 지속적 포도당 모니터링 기기에 사용됩니다. 병원, 진료소, 재택 의료가 주요 최종사용자입니다. 북미는 당뇨병 유병률이 높고 의료 인프라가 발달해 시장을 주도하고 있지만, 아시아태평양은 당뇨병 유병률 증가와 의료 접근성 향상으로 인해 빠르게 성장하고 있습니다.

기술의 발전은 글루코스 바이오센서에 어떤 영향을 미치고 있는가?

기술 혁신은 특히 비침습적 모니터링, 센서의 정확성, 디지털 건강 플랫폼과의 통합 분야에서 글루코스 바이오센서의 개선을 촉진하고 있습니다. 웨어러블 센서를 통해 실시간 데이터를 제공하는 연속 혈당 모니터링(CGM) 시스템은 손가락을 자주 찔러야 하는 검사의 필요성을 줄임으로써 당뇨병 관리를 혁신적으로 변화시키고 있습니다. 센서의 소형화, 생체적합성 소재, 무선 연결의 발전으로 인해 이러한 장치는 환자에게 더 편안하고 편리하게 사용할 수 있게 되었습니다. 글루코스 바이오센서를 모바일 앱 및 클라우드 플랫폼과 통합함으로써 환자와 의료진은 추세를 추적하고 데이터에 기반한 의사결정을 내릴 수 있습니다. 또한, 광학 및 경피 센서와 같은 비침습적 포도당 모니터링 방법에 대한 연구는 당뇨병 치료의 미래에 유망합니다.

글루코스 바이오센서 시장의 성장을 촉진하는 요인은 무엇인가?

글루코스 바이오센서 시장의 성장은 전 세계 당뇨병 유병률 증가와 지속적인 실시간 포도당 모니터링 솔루션에 대한 수요 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 센서의 정확도 향상, 소형화, 비침습적 모니터링 기술 등 바이오센서 기술의 발전은 환자 경험을 개선하고 임상 및 가정 환경 모두에서 글루코스 바이오센서의 사용을 확대하고 있습니다. 당뇨병 관리 개선을 위한 정부의 노력과 의료 정책은 첨단 혈당 모니터링 기기의 채택을 더욱 촉진하고 있습니다. 또한, 글루코스 바이오센서와 디지털 헬스 플랫폼의 통합이 확대되고, 환자와 의료진 간의 소통과 데이터 분석이 개선되면서 시장 성장에 기여하고 있습니다.

조사 대상 기업 예시(총 42건)

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agamatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.10.31

Global Glucose Biosensors Market to Reach US$4.1 Billion by 2030

The global market for Glucose Biosensors estimated at US$3.6 Billion in the year 2023, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Homecare Diagnostics End-Use segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$960.3 Million While China is Forecast to Grow at 3.1% CAGR

The Glucose Biosensors market in the U.S. is estimated at US$960.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$765.6 Million by the year 2030 trailing a CAGR of 3.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Glucose Biosensors Market - Key Trends and Drivers Summarized

How Are Glucose Biosensors Enhancing Diabetes Management?

Glucose biosensors are critical tools in the management of diabetes, providing real-time monitoring of blood glucose levels for patients. These sensors, which are integral to glucose meters and continuous glucose monitoring (CGM) devices, measure the concentration of glucose in the blood using enzymatic reactions and electrochemical detection methods. Continuous glucose monitoring systems, which offer around-the-clock tracking, have significantly improved diabetes management by providing patients with more data to make informed decisions about their insulin dosing, diet, and activity. With the rising prevalence of diabetes worldwide, the demand for accurate, reliable, and user-friendly glucose biosensors is on the rise, helping patients maintain better control over their condition.

What Are the Key Segments and Applications of Glucose Biosensors?

The glucose biosensors market is segmented by technology, including electrochemical, optical, and enzymatic biosensors. Electrochemical biosensors, which measure glucose concentration through electrical signals generated by enzymatic reactions, dominate the market due to their accuracy, affordability, and widespread use in CGM devices and glucose meters. Optical biosensors, which use light-based detection methods, are also gaining traction, particularly for non-invasive monitoring systems. In terms of application, glucose biosensors are primarily used in self-monitoring blood glucose (SMBG) systems and continuous glucose monitoring devices. Hospitals, clinics, and home healthcare settings represent the primary end-users. North America leads the market due to the high prevalence of diabetes and advanced healthcare infrastructure, while Asia-Pacific is experiencing rapid growth as diabetes rates rise and access to healthcare improves.

How Are Technological Advancements Impacting Glucose Biosensors?

Technological innovations are driving improvements in glucose biosensors, particularly in the areas of non-invasive monitoring, sensor accuracy, and integration with digital health platforms. Continuous glucose monitoring (CGM) systems, which provide real-time data through wearable sensors, have transformed diabetes management by reducing the need for frequent finger-prick tests. Advances in sensor miniaturization, biocompatible materials, and wireless connectivity are making these devices more comfortable and convenient for patients. The integration of glucose biosensors with mobile apps and cloud platforms is enabling patients and healthcare providers to track trends and make data-driven decisions. Additionally, research into non-invasive glucose monitoring methods, such as optical and transdermal sensors, holds promise for the future of diabetes care.

What Factors Are Driving the Growth in the Glucose Biosensors Market?

The growth in the glucose biosensors market is driven by several factors, including the rising global prevalence of diabetes and the increasing demand for continuous, real-time glucose monitoring solutions. Advances in biosensor technology, including improvements in sensor accuracy, miniaturization, and non-invasive monitoring techniques, are enhancing the patient experience and expanding the use of glucose biosensors in both clinical and home settings. Government initiatives and healthcare policies aimed at improving diabetes management are further supporting the adoption of advanced glucose monitoring devices. The growing integration of glucose biosensors with digital health platforms, enabling better patient-provider communication and data analysis, is also fueling market growth.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • AgaMatrix Inc.
  • Bayer
  • Biacore
  • BioSense Medical Devices, LLC
  • Biosensors International Pte. Ltd.
  • LifeScan, Inc.
  • LifeSensors, Inc.
  • Medtronic, Inc.
  • Nova Biomedical
  • Pharmaco-Kinesis Corporation
  • Pinnacle Medical Solutions, Inc.
  • Roche Diagnostics
  • Sanofi S.A.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Glucose Biosensors - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Globally Propels Demand for Glucose Biosensors
    • Technological Innovations in Continuous Glucose Monitoring (CGM) Devices Strengthen Market Growth
    • Increasing Adoption of Wearable Glucose Biosensors Drives Market Expansion
    • Growing Focus on Non-Invasive Glucose Monitoring Technologies Creates Opportunities
    • Rising Demand for Portable and Convenient Glucose Monitoring Devices Expands Addressable Market
    • Advancements in Sensor Accuracy and Reliability Propel Adoption of Glucose Biosensors
    • Increasing Integration of Biosensors with Mobile Apps and Cloud Platforms Boosts Demand
    • Rising Adoption of Glucose Biosensors in Personalized Medicine Strengthens Business Case
    • Growing Preference for Continuous Glucose Monitoring over Traditional Testing Methods Drives Growth
    • Technological Developments in Miniaturized and Implantable Biosensors Spur Innovation
    • Rising Demand for Real-Time Monitoring Solutions in Healthcare Expands Market for Biosensors
    • Growing Healthcare Expenditure and Insurance Coverage for Diabetes Management Support Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Glucose Biosensors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Homecare Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Homecare Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Glucose Biosensors Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Glucose Biosensors by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Glucose Biosensors by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Glucose Biosensors by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Glucose Biosensors by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Glucose Biosensors by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Glucose Biosensors Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Glucose Biosensors by End-Use - Hospitals, Homecare Diagnostics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Glucose Biosensors by End-Use - Percentage Breakdown of Value Sales for Hospitals, Homecare Diagnostics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제